What is RevBio?
RevBio, headquartered in Lowell, Massachusetts, is a biotechnology company focused on developing innovative bone repair applications. The company's core technology is a patented bioadhesive, reverse-engineered from a mineral-organic compound inspired by the Sandcastle Worm. This biomimetic adhesive platform is designed for extensive use in bone repair. As a MassChallenge start-up accelerator alum, RevBio has demonstrated a strong foundation through numerous grants and multiple patents, and is currently advancing its technology through a first-in-human clinical trial.
How much funding has RevBio raised?
RevBio has raised a total of $10M across 1 funding round:
Debt
$10M
Debt (2025): $10M, investors not publicly disclosed
What's next for RevBio?
The recent major strategic investment signals a pivotal growth phase for RevBio, likely enabling the company to accelerate its clinical trial progress, scale manufacturing capabilities, and expand its market reach for its unique bone repair adhesive. This enterprise-level funding is expected to fuel further research and development, solidifying its position in the regenerative medicine sector.
See full RevBio company page
